Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
about
In vitro evaluation of guanidine analogs as sigma receptor ligands for potential anti-stroke therapeuticsCombination Low-Dose Tissue-Type Plasminogen Activator Plus Annexin A2 for Improving Thrombolytic Stroke TherapyMedicolegal considerations with intravenous tissue plasminogen activator in stroke: a systematic reviewAnti-Inflammation of Natural Components from Medicinal Plants at Low Concentrations in Brain via Inhibiting Neutrophil Infiltration after StrokeCurrent perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic strokeMultiple causes for delay in arrival at hospital in acute stroke patients in Aydin, Turkey.A comprehensive review of prehospital and in-hospital delay times in acute stroke care.Angiogenesis, neurogenesis and brain recovery of function following injuryTreatment of Cervical Artery Dissection: Antithrombotics, Thrombolysis, and Endovascular TherapyTime-critical neurological emergencies: the unfulfilled role for point-of-care testing.NANOMATERIALS FOR PROTEIN MEDIATED THERAPY AND DELIVERY.Early exercise improves cerebral blood flow through increased angiogenesis in experimental stroke rat modelMedico-legal aspects of using tissue plasminogen activator in acute ischemic strokeThrombolytic therapy for acute ischemic stroke beyond three hours.Pharmaceutical sponsorship bias influences thrombolytic literature in acute ischemic strokeCalcium-permeable ion channels involved in glutamate receptor-independent ischemic brain injuryFuture neurohospitalist: teleneurohospitalist.Neuronal plasticity and functional recovery after ischemic stroke.Use of telemedicine and helicopter transport to improve stroke care in remote locationsAcute bioenergetic intervention or pharmacological preconditioning protects neuron against ischemic injury.Buyang Huanwu decoction increases angiopoietin-1 expression and promotes angiogenesis and functional outcome after focal cerebral ischemia.The Continued Promise of Neuroprotection for Acute Stroke Treatment.The role of ASICS in cerebral ischemia.When to randomize, or 'Evidence-based medicine needs medicine-based evidence'.Targeting therapeutics to endothelium: are we there yet?TRPM7 is a unique target for therapeutic intervention of stroke.Danhong Injection Combined With t-PA Improves Thrombolytic Therapy in Focal Embolic Stroke.Description of a novel telemedicine-enabled comprehensive system of care: drip and ship plus drip and keep within a system of stroke care delivery.
P2860
Q24594024-3BDE1321-F301-4263-838A-85D1889D2191Q26777274-0496756A-0A3B-403A-A292-D2370BF4B125Q26849573-41AD3CF1-20B9-4AAC-9494-5EB0799C3BACQ28072829-F5883AD4-FA95-484D-8F52-7903BDFAEF4FQ30414441-A31B46B1-7F26-4F8A-9F15-A8A4E0DFE375Q33334243-46D72EA9-16E3-4381-8635-F095B3390242Q33671817-B76D65A0-F40E-41DA-94C1-0688D5E02524Q33718009-D5C62258-088B-4649-B6D0-526AA2161C12Q33760166-9D535131-9E82-4F18-8207-593152818363Q33911520-909A6A95-4E40-4D00-94C2-E1567CA1F9B4Q34534023-BE87FAD0-6307-413F-8554-A6F0E0E51FECQ34691016-E9AA3901-72A3-4AC3-AE56-006A7A07A0E1Q34901690-A8FCBE32-164B-4CE6-AA99-2210308E3CE3Q35552867-AD86AABE-A46A-4201-AF94-099390E17C60Q35608208-12B6BEF3-6B27-4758-8E3E-00D285D19E6FQ36090699-2F6BFBE8-5DB1-4AF4-8366-B1571E05A77AQ37052779-5AF62E7F-296D-4311-ADC7-D136B396F033Q37077099-DC94C4AA-758C-412F-897B-87EEFB1683E0Q37118958-3CEC5044-A4E4-4DF4-AD35-9CBAFBE01A2DQ37340968-AC95FB70-A70A-4DCB-942E-C7B7DA329CC1Q37640402-F247C8D9-70CC-4EF6-8B26-B96A3F2AF7FFQ37701718-18A411B9-968B-4916-AED2-A87E5DD1ED0EQ41521801-D4AF4674-1E94-414C-A66D-EB2219BC851DQ45384505-01B1C479-F539-43D6-A424-F1117A856EFBQ47250590-0DB84489-8B36-4FD6-8831-79E2D5F51E70Q47852921-AEFC7534-AF1B-41E6-937C-C2C871D782BFQ52691666-DC337E60-2A0D-4195-BD5C-A371603D0CAFQ53146465-9D19E555-8E45-4BB4-9566-E737E1548F80
P2860
Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
@ast
Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
@en
type
label
Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
@ast
Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
@en
prefLabel
Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
@ast
Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
@en
P1433
P1476
Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire.
@en
P2093
Michael I Weintraub
P304
P356
10.1161/01.STR.0000226651.04862.DA
P407
P577
2006-05-25T00:00:00Z